eczema. Flexural eczema
Conditions
Interventions
Intervention 1: The first intervention group uses triamcinolone cream 0.01% from Iran Daru factory twice a day for one month on the hands, and then the use is stopped and follow-up is carried out for
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients who have hand eczema and patients have not been treated in the last month.
Exclusion criteria
Exclusion criteria: There are patients who are taking another medicine Patients who do not have the possibility to refer for the necessary follow-up Patients who have other accompanying skin disease in the hand area other than eczema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Itching score. Timepoint: 4 weeks after treatment and 4 weeks after follow-up. Method of measurement: Itching is given a score from 1 to 10, and for each individual cream before treatment, after 4 weeks of treatment, and after 4 weeks of follow-up, patients' itching is scored in order to check the therapeutic effect of the drugs used.;Dryness score. Timepoint: 4 weeks after treatment and 4 weeks after follow-up. Method of measurement: Dryness is given a score from 1 to 10, and for each individual cream before treatment, after 4 weeks of treatment and after 4 weeks of follow-up, patients' dryness is scored in order to check the therapeutic effect of the drugs used.;Burning score. Timepoint: 4 weeks after treatment and 4 weeks after follow-up. Method of measurement: Burning is given a score from 1 to 10, and for each individual cream before treatment, after 4 weeks of treatment and after 4 weeks of follow-up, patients' burning is scored to check the therapeutic effect of the drugs used.;Erythema score. Timepoint: 4 weeks after treatment and 4 weeks after follow-up. Method of measurement: Erythema is given a score from 1 to 10, and for each individual cream before treatment, after 4 weeks of treatment and after 4 weeks of follow-up, patients' erythema is scored to check the therapeutic effect of the drugs used.;Satisfaction with treatment. Timepoint: 4 weeks after treatment and 4 weeks after follow-up. Method of measurement: To evaluate patients' satisfaction with treatment, Vas Score is recorded.;Eczema severity. Timepoint: Before the start of treatment, the end of 4 weeks of treatment and the end of 4 weeks of follow-up. Method of measurement: Hand eczema severity index (HECSI) score is used for patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParisa Mohammadian
Esfahan University of Medical Sciences
Outcome results
None listed